Seroatlas · Human Serome Atlas

CHI3L2

Chitinase-3-like protein 2

Also known as: CH3L2_HUMAN, YKL-39, YKL39

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q15782
Gene
CHI3L2
Ensembl
ENSG00000064886
Chromosome
1
Canonical length
390 aa
Protein class
Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

The protein encoded by this gene is similar to bacterial chitinases but lacks chitinase activity. The encoded protein is secreted and is involved in cartilage biogenesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Canonical amino-acid sequenceUniProt

390 residues, UniProt reviewed canonical sequence.

>Q15782|CHI3L2
     1  MGATTMDQKS LWAGVVVLLL LQGGSAYKLV CYFTNWSQDR QEPGKFTPEN IDPFLCSHLI
    61  YSFASIENNK VIIKDKSEVM LYQTINSLKT KNPKLKILLS IGGYLFGSKG FHPMVDSSTS
   121  RLEFINSIIL FLRNHNFDGL DVSWIYPDQK ENTHFTVLIH ELAEAFQKDF TKSTKERLLL
   181  TAGVSAGRQM IDNSYQVEKL AKDLDFINLL SFDFHGSWEK PLITGHNSPL SKGWQDRGPS
   241  SYYNVEYAVG YWIHKGMPSE KVVMGIPTYG HSFTLASAET TVGAPASGPG AAGPITESSG
   301  FLAYYEICQF LKGAKITRLQ DQQVPYAVKG NQWVGYDDVK SMETKVQFLK NLNLGGAMIW
   361  SIDMDDFTGK SCNQGPYPLV QAVKRSLGSL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CHI3L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.25
Highest tissue expression
187 nTPM

Expression across tissuesHPA

Tissue

  • thymus: 187 nTPM
  • salivary gland: 134 nTPM
  • tonsil: 111 nTPM
  • appendix: 106 nTPM
  • lung: 70 nTPM
  • spinal cord: 56 nTPM

Single-cell type

  • lacrimal acinar cells: 597 nCPM
  • salivary acinar cells: 571 nCPM
  • alveolar cells type 2: 89 nCPM
  • breast secretory cells: 85 nCPM
  • salivary myoepithelial cells: 80 nCPM
  • decidual stromal cells: 57 nCPM

Immune cell

  • naive CD4 T-cell: 92 nTPM
  • memory B-cell: 45 nTPM
  • naive B-cell: 43 nTPM
  • memory CD8 T-cell: 38 nTPM
  • naive CD8 T-cell: 34 nTPM
  • total PBMC: 27 nTPM

Brain region

  • medulla oblongata: 117 nTPM
  • thalamus: 61 nTPM
  • pons: 59 nTPM
  • white matter: 40 nTPM
  • spinal cord: 26 nTPM
  • cerebral cortex: 26 nTPM

ReferencesPubMed · IEDB

Publications for CHI3L2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.45
gnomAD pLI
0
gnomAD missense Z
-0.43
DepMap mean gene effect
-0.09
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CHI3L2 as an antibody target. Whether an autoantibody or antibody against CHI3L2 could matter depends on whether native CHI3L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CHI3L2 is annotated as secreted, so native CHI3L2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CHI3L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CHI3L2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...